Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MIF | P14174 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL20897413 | 0.97 | CYP2D6 (0.46) | HCAR2TAAR1ADRA2AADRA2CADRA2B | |
| SCHEMBL8750423 | 0.92 | PTGS2 (0.43) | HCAR2TAAR1ADRA2AADRA2CADRA2B | |
| SCHEMBL8750413 | 0.90 | ESR1 (0.42) | HCAR2TAAR1ADRA2AADRA2CADRA2B | |
| SCHEMBL17367389 | 0.89 | HCAR2 (0.42) | HCAR2TAAR1ADRA2AADRA2CADRA2B | |
| SCHEMBL13554105 | 0.89 | HCAR2 (0.42) | HCAR2TAAR1ADRA2AADRA2CADRA2B | |
| SCHEMBL3163758 | 0.89 | HCAR2 (0.42) | HCAR2TAAR1ADRA2AADRA2CADRA2B | |
| SCHEMBL104838 | 0.89 | HCAR2 (0.42) | HCAR2TAAR1ADRA2AADRA2CADRA2B | |
| Ethylene Glycol SCHEMBL2680753 | 0.88 | TRPA1 (0.47) | HCAR2TAAR1ADRA2AADRA2CLMNA | |
| SCHEMBL6272307 | 0.87 | HCAR2 (0.46) | HCAR2TAAR1ADRA2AADRA2CADRA2B | |
| SCHEMBL8051819 | 0.86 | HCAR2 (0.38) | HCAR2TAAR1ADRA2AADRA2CADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118268030-A | Solid sulfonic acid catalyst and preparation method and application thereof | 华东理工大学 | 2024-07-02 | — | — | CN | claimed |
| WO-2023130587-A1 | WATER-SOLUBLE METHYLBENZENE ETHER DERIVATIVE, POSITRON NUCLIDE PROBE AND NUCLIDE MARKER, AND PREPARATION METHODS THEREFOR AND USES THEREOF | 四川大学华西医院 | 2023-07-13 | — | — | WO | claimed |
| WO-2023033605-A1 | METHOD FOR SCREENING SOLVENT FOR EXTRACTING POLYVINYL CHLORIDE, METHOD FOR RECYCLING WASTE, RECYCLED POLYVINYL CHLORIDE, AND COMPOSITION | 주식회사 엘지화학 | 2023-03-09 | — | — | WO | claimed |
| WO-2023033601-A1 | METHOD FOR SCREENING SOLVENT FOR POLYVINYL CHLORIDE EXTRACTION, RECYCLING METHOD FOR WASTE MATERIAL, AND RECYCLED POLYVINYL CHLORIDE AND COMPOSITION | 주식회사 엘지화학 | 2023-03-09 | — | — | WO | claimed |
| CN-114573558-B | Water-soluble methyl benzyl ether derivative, positron nuclide probe, nuclide marker, preparation method and application | 四川大学华西医院 | 2022-11-08 | — | — | CN | claimed |
| CN-114573558-A | Water-soluble methyl benzyl ether derivative, positron nuclide probe, nuclide marker, preparation method and application | 四川大学华西医院 | 2022-06-03 | — | — | CN | claimed |
| US-11192853-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2021-12-07 | — | — | US | claimed |
| CN-113105315-A | Method for synthesizing high-concentration 3-hydroxypropionaldehyde by continuous catalytic reaction | 上海师范大学 | 2021-07-13 | — | — | CN | claimed |
| WO-2021103220-A1 | ANHYDROUS DYEING DISPERSE DYE PASTE, PREPARATION METHOD AND USE | 海宁绿宇纺织科技有限公司 | 2021-06-03 | — | — | WO | claimed |
| WO-2021042314-A1 | ORGANIC-INORGANIC HYBRID MATERIAL, PREPARATION METHOD THEREFOR AND METHOD FOR PREPARING STARTING MATERIAL THEREOF | 诠达化学股份有限公司 | 2021-03-11 | — | — | WO | claimed |
| US-4521636-A | CONDENSATION OF ALPHA ALKYLBENZYL ALCOHOL IN PRESENCE OF ALUMINUM SULFATE CATALYST | ATLANTIC RICHFIELD COMPANY (US) | 1985-06-04 | — | — | US | claimed |
| US-4521635-A | USING ACID-TREATED ALUMINA CATALYST | ATLANTIC RICHFIELD COMPANY (US) | 1985-06-04 | — | — | US | claimed |
| US-4521637-A | ETHERIFICATION OF ALPHA-ALKYLBENZYL ALCOHOL USING ACID TREATED ALUMINA CATALYST | ATLANTIC RICHFIELD COMPANY (US) | 1985-06-04 | — | — | US | claimed |
| US-4518806-A | Production of aryl alkyl ethers from methylbenzyl alcohol using bis-(dithiobenzyl)nickel(II) catalyst | ATLANTIC RICHFIELD COMPANY (US) | 1985-05-21 | — | — | US | claimed |
| US-4514576-A | Production of aryl alkyl ethers from methylbenzyl alcohol using rhenium heptoxide catalyst | ATLANTIC RICHFIELD COMPANY (US) | 1985-04-30 | — | — | US | claimed |
| US-4341820-A | Composition of matter | OWENS-ILLINOIS, INC. (US) | 1982-07-27 | — | — | US | claimed |
| US-4298516-A | Composition of matter | OWENS-ILLINOIS, INC. (US) | 1981-11-03 | — | — | US | claimed |
| US-4256645-A | OXIDATION WITH PALLADIUM OR PLATINUM CATALYST IN ORGANIC SOLVENT | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-03-17 | — | — | US | claimed |
| US-4061638-A | Organocalciumpyridine-type polymerization initiators | PHILLIPS PETROLEUM COMPANY (US) | 1977-12-06 | — | — | US | claimed |
| US-4014845-A | Fugitive vehicle system | OWENS-ILLINOIS, INC. (US) | 1977-03-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11192853-B2 | Separation method and method for producing isocyanate | IDH3A, IDH3B, CA9 | HCAR2 2076/4885TAAR1 3618/4885ADRA2A 4074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.